U.S., Aug. 20 -- An application to own the trademark for 'N-TAB' has been filed on Aug. 15, 2024.
Owner(s):
Entera Bio Ltd.; Hadassah Ein-Kerem, 9112002 Jerusalem, ISRAEL
Goods and/or Services:
For: pharmaceutical preparations, namely, drug delivery agents in the form of tablets that enable oral delivery of proteins and peptides; pharmaceutical preparations for use as peptide replacement therapy; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of metabolic conditions; pharmaceutical preparations for the treatment of short bowel syndrome; pharmaceutical...